Intrathecal S ( + )-ketamine in refractory neuropathic cancer pain

Shields KG, Levy MJ, Goadsby PJ. Alopecia and cutaneous atrophy following greater occipital nerve infiltration. Neurology 2004;63:2193–4. Mir P, Alberca R, Navarro A, et al. Prophylactic treatment of episodic cluster headache with intravenous bolus of methylprednisolone. Neurol Sci 2003;24(5):318–21. Cianchetti C, Zuddas A, Marchei F. High dose intravenous methylprednisolone in cluster headache. J Neurol Neurosurg Psychiatry 1998;64(3):418. Anthony M. The role of the occipital nerve in unilateral headache. In: Anthony Rose FC, editor. Current Problems in Neurology. Advances in Headache Research, vol. 4. London, UK: John Libbey; 1987. p. 257–62.

[1]  D. Troost,et al.  Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain , 2005, Pain.

[2]  H. Kress,et al.  Long-term intrathecal S(+)-ketamine in a patient with cancer-related neuropathic pain. , 2005, British journal of anaesthesia.

[3]  T. Yaksh,et al.  The Use of Intrathecal Midazolam in Humans: A Case Study of Process , 2004, Anesthesia and analgesia.

[4]  J. Kal,et al.  Treatment of neuropathic cancer pain with continuous intrathecal administration of S (+)‐ketamine , 2004, Acta anaesthesiologica Scandinavica.

[5]  T. Yaksh,et al.  Epidural ketamine in healthy children--what's the point? , 2003, Anesthesia and analgesia.

[6]  H. Kress,et al.  The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance. , 2001, Anesthesia and analgesia.

[7]  H. Gerber,et al.  Histological findings after long-term infusion of intrathecal ketamine for chronic pain: a case report. , 1999, Journal of pain and symptom management.

[8]  C. Errando,et al.  Subarachnoid ketamine in swine--pathological findings after repeated doses: acute toxicity study. , 1999, Regional anesthesia and pain medicine.

[9]  E. Masliah,et al.  Subpial vacuolar myelopathy after intrathecal ketamine: report of a case , 1997, Pain.

[10]  J. Lange,et al.  Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/ bupivacaine mixture in cancer pain patients , 1997, Acta anaesthesiologica Scandinavica.

[11]  J. Mussini,et al.  Is Ketamine or Its Preservative Responsible for Neurotoxicity in the Rabbit? , 1993, Anesthesiology.

[12]  C. Nordborg,et al.  Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. , 1992, Anesthesiology.

[13]  J. Brock‐Utne,et al.  Effects of intrathecal saline and ketamine with and without preservative on the spinal nerve roots of monkeys. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.